We evaluated the +331G/A PgR promoter polymorphism for two reasons: (1) its association with many cancers like endometrial, ovarian and breast cancer, although there are conflicting observations and (2) the functional attribute of +331G/A PgR has been delineated and has been found to play an important role in hormone related cancer. Here, PGR is linked to breast carcinoma.